A Rollover Study of ARRY-371797 in Patients With LMNA-Related Dilated Cardiomyopathy
Status: | Active, not recruiting |
---|---|
Conditions: | Cardiology, Cardiology |
Therapuetic Areas: | Cardiology / Vascular Diseases |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 3/2/2019 |
Start Date: | February 2015 |
End Date: | February 2022 |
This is a rollover study designed to investigate the safety and effectiveness of
investigational study drug ARRY-371797 in patients who previously received ARRY-371797 in a
study for patients with LMNA-related dilated cardiomyopathy sponsored by Array BioPharma and
may, in the Investigator's opinion, derive benefit from continued treatment.
investigational study drug ARRY-371797 in patients who previously received ARRY-371797 in a
study for patients with LMNA-related dilated cardiomyopathy sponsored by Array BioPharma and
may, in the Investigator's opinion, derive benefit from continued treatment.
Key Inclusion Criteria:
- Received ARRY-371797 as treatment for a genetic dilated cardiomyopathy secondary to
LMNA mutations in a clinical study sponsored by Array BioPharma.
- May, in the opinion of the Investigator, benefit from continued ARRY-371797 treatment.
- Additional criteria exist.
Key Exclusion Criteria:
- Discontinued treatment in the parent study for any reason other than study completion
or Sponsor termination of the study.
- Additional criteria exist.
We found this trial at
4
sites
Click here to add this to my saved trials
3400 N Charles St
Baltimore, Maryland 21205
Baltimore, Maryland 21205
410-516-8000
Phone: 410-502-7310
Johns Hopkins University The Johns Hopkins University opened in 1876, with the inauguration of its...
Click here to add this to my saved trials
75 Francis street
Boston, Massachusetts 02115
Boston, Massachusetts 02115
(617) 732-5500
Principal Investigator: Calum MacRae, MD
Brigham and Women's Hosp Boston’s Brigham and Women’s Hospital (BWH) is an international leader in...
Click here to add this to my saved trials
Click here to add this to my saved trials